BTS' Jimin Updates Fans After Appendicitis Surgery & COVID Battle

By Emily Lee

February 3, 2022

Photo: Getty Images

Jimin is on the mend after falling ill earlier this week. The BTS member simultaneously came down with appendicitis and COVID-19. The 26-year-old pop star underwent surgery for his acute appendicitis after experiencing abdominal pain and a sore throat. While hospitalized, Jimin tested positive for COVID.

"We would like to provide you with the following information regarding the current health status of BTS member Jimin," a statement from the band's management, Big Hit Music, informed fans earlier this week. "Jimin experienced sudden abdominal pain along with a mild sore throat. He visited a hospital emergency room for a thorough examination, and also took a PCR test. Jimin was diagnosed with acute appendicitis and tested positive for Covid-19. He underwent surgery following physician advice."

“According to the medical staff, the surgery was successful and Jimin is currently recuperating after his procedure," the statement continued. "He will be receiving a few days of in-patient treatment for Covid-19 in conjunction with postoperative care. He is currently experiencing a mild sore throat but is making a speedy recovery, and had no contact with the other band members during the infectious stage."

After spending a few days recovering, Jimin was able to update fans on his health. "Sorry for making you worry," he wrote in a Weverse statement, translated and shared by a fan. "However, I think I'll be able to get discharged soon! I'm recovering well and I'm making sure to take care and eat all three meals. Please just wait a little bit. I'll recover quickly and go!"

Jimin is the fourth member of BTS, which consists of seven singers, to contract COVID-19 recently. Earlier this month, Big Hit Music revealed RM, Jin, and Suga had all contracted the virus. RM, Jin and Suga have all recovered.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.


© 2024 iHeartMedia, Inc.